Literature DB >> 16617117

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Marc A Gavin1, Troy R Torgerson, Evan Houston, Paul DeRoos, William Y Ho, Asbjørg Stray-Pedersen, Elizabeth L Ocheltree, Philip D Greenberg, Hans D Ochs, Alexander Y Rudensky.   

Abstract

Forkhead winged-helix transcription factor Foxp3 serves as the dedicated mediator of the genetic program governing CD25+CD4+ regulatory T cell (T(R)) development and function in mice. In humans, its role in mediating T(R) development has been controversial. Furthermore, the fate of T(R) precursors in FOXP3 deficiency has yet to be described. Making use of flow cytometric detection of human FOXP3, we have addressed the relationship between FOXP3 expression and human T(R) development. Unlike murine Foxp3- T cells, a small subset of human CD4+ and CD8+ T cells transiently up-regulated FOXP3 upon in vitro stimulation. Induced FOXP3, however, did not alter cell-surface phenotype or suppress T helper 1 cytokine expression. Furthermore, only ex vivo FOXP3+ T(R) cells persisted after prolonged culture, suggesting that induced FOXP3 did not activate a T(r) developmental program in a significant number of cells. FOXP3 flow cytometry was also used to further characterize several patients exhibiting symptoms of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) with or without FOXP3 mutations. Most patients lacked FOXP3-expressing cells, further solidifying the association between FOXP3 deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Interestingly, one patient bearing a FOXP3 mutation enabling expression of stable FOXP3(mut) protein exhibited FOXP3(mut)-expressing cells among a subset of highly activated CD4+ T cells. This observation raises the possibility that the severe autoimmunity in FOXP3 deficiency can be attributed, in part, to aggressive T helper cells that have developed from T(R) precursors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617117      PMCID: PMC1458937          DOI: 10.1073/pnas.0509484103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.

Authors:  Mindi R Walker; Bryan D Carson; Gerald T Nepom; Steven F Ziegler; Jane H Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 3.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

Authors:  Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

4.  Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.

Authors:  Reginald M Gorczynski; Lydia Lee; Ivo Boudakov
Journal:  Transplantation       Date:  2005-05-15       Impact factor: 4.939

5.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

6.  Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells.

Authors:  Clare Baecher-Allan; Elizabeth Wolf; David A Hafler
Journal:  Clin Immunol       Date:  2005-04       Impact factor: 3.969

7.  Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

Authors:  Mary E Morgan; Jolanda H M van Bilsen; Aleida M Bakker; Bianca Heemskerk; Marco W Schilham; Franca C Hartgers; Berendina G Elferink; Linda van der Zanden; René R P de Vries; Tom W J Huizinga; Tom H M Ottenhoff; René E M Toes
Journal:  Hum Immunol       Date:  2005-01       Impact factor: 2.850

8.  Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.

Authors:  E Ashley Moseman; Xueqing Liang; Amanda J Dawson; Angela Panoskaltsis-Mortari; Arthur M Krieg; Yong-Jun Liu; Bruce R Blazar; Wei Chen
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

9.  Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.

Authors:  Haruhiko Yagi; Takashi Nomura; Kyoko Nakamura; Sayuri Yamazaki; Toshio Kitawaki; Shohei Hori; Michiyuki Maeda; Masafumi Onodera; Takashi Uchiyama; Shingo Fujii; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2004-10-04       Impact factor: 4.823

10.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Authors:  Giovanna Roncador; Philip J Brown; Lorena Maestre; Sophie Hue; Jorge L Martínez-Torrecuadrada; Khoon-Lin Ling; Sarah Pratap; Christy Toms; Bridget C Fox; Vincenzo Cerundolo; Fiona Powrie; Alison H Banham
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

View more
  290 in total

1.  Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.

Authors:  E Ilker Ozay; Sudarvili Shanthalingam; Joe A Torres; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

2.  Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.

Authors:  Patrick J Schuler; Malgorzata Harasymczuk; Bastian Schilling; Stephan Lang; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2011-04-13       Impact factor: 2.303

3.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

4.  Perspectives on Regulatory T Cell Therapies.

Authors:  Michael Probst-Kepper; Andrea Kröger; Henk S P Garritsen; Jan Buer
Journal:  Transfus Med Hemother       Date:  2009-09-10       Impact factor: 3.747

5.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Authors:  Madhav D Sharma; Babak Baban; Phillip Chandler; De-Yan Hou; Nagendra Singh; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

Review 7.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

8.  Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Authors:  Khalid Bin Dhuban; Eva d'Hennezel; Emil Nashi; Amit Bar-Or; Sadiye Rieder; Ethan M Shevach; Satoshi Nagata; Ciriaco A Piccirillo
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.

Authors:  Daniel J Powell; Aloisio Felipe-Silva; Maria J Merino; Mojgan Ahmadzadeh; Tamika Allen; Catherine Levy; Donald E White; Sharon Mavroukakis; Robert J Kreitman; Steven A Rosenberg; Ira Pastan
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

10.  Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

Authors:  C Preston Neff; Matthew E Rhodes; Kathleen L Arnolds; Colm B Collins; Jody Donnelly; Nichole Nusbacher; Paul Jedlicka; Jennifer M Schneider; Martin D McCarter; Michael Shaffer; Sarkis K Mazmanian; Brent E Palmer; Catherine A Lozupone
Journal:  Cell Host Microbe       Date:  2016-09-29       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.